发明人徐明华,钱学锋,杨光. "Method for the Synthesis of ethyl (2Z)-2-cyano-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylamino)prop-2-enoate" [P]. 中国发明专利, 专利号 CN 113736451 B, 授权公告日 2018-10-13.
Hughes D C, Klinger H, Roberts E F. "A Process for Preparing High-Purity ethyl (2Z)-2-cyano-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylamino)prop-2-enoate" [P]. US Patent, US 11492693 B2, 2020-04-02.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of ethyl (2Z)-2-cyano-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylamino)prop-2-enoate in Pharmaceutical Formulations". Environ. Sci. Technol., 2020, 172, (2), 1116-1142.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of ethyl (2Z)-2-cyano-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylamino)prop-2-enoate as an Impurity". J. Chromatogr. A, 2011, 479, (2), 2183-2196.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of ethyl (2Z)-2-cyano-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylamino)prop-2-enoate Using HRMS and NMR". J. Agric. Food Chem., 2025, 552, (2), 5154-5159.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate ethyl (2Z)-2-cyano-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylamino)prop-2-enoate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2012, 1994, 6729-6746.